Dr. Reddy’s launches Alkeran generic
Dr. Reddy’s has announced the launch of melphalan hydrochloride for injection, which has been approved by the Food and Drug Administration. This latest product is a therapeutic equivalent generic version of Alkeran.
The company’s Melphalan Hydrochloride for injection is available in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.
The Alkeran brand and generic had U.S. sales of approximately $107 million MAT for the most recent 12 months ended October 2017, according to IQVIA data.